Last Price | 31.71 | Max Price | 39.35 |
Min Price | 22.84 | 1 Year return | -66.43 |
Avg. Target | 32.05 | Expected Return | 1.06 % |
Sector | Industry | Subsector | Diversified Industrials |
Sell | 2 | Rating | |
Hold | 4 | Concensus | |
Buy | 6 | ||
Annual report 2018 |
Solvay is a Belgian pharmaceutical company producing pharmaceuticals, chemical and man-made substances. Solvay is mainly active in the medical care, construction and car industries. Well known Solvay brands include ‘Androgel’, ‘Prometrium’ and ‘Marinol’. (ISIN: BE0003470755 / Mnemo: SOLB)
Solvay is the Belgium-based international chemical conglomerate, primarily in involved in the production of specialized pharmaceuticals plastics and chemicals. The main offerings of the firm include the manufacturing of broad-range products used contributing to the increased standard of living and sales among users, mainly marketed in the fields of electronics, environment, water, energy, automobile, construction and other consumer-goods. The company was founded back in the year of 1863 by Ernest Solvay, giving his name to the company and currently the company headquarter is located in Neder Over Heembeek, Brussels, Belgium.
The employees count of the company is 30,000 which are distributed in the diversified units of the company in 55 countries all over the world. The managing authorities of the company are Nicolas Boel as the Chairman and Jean Pierre Clamadieu as the Chief Executive Officer of the company. One of the main auxiliary units of the group named as Solvay America Inc. is being located in Houston in Texas.
The revenue generation of the company is 12.83 billion € with the profitability amount of 710 million €, making the total assets of the company to be 18.23 billion € and overall equity to be 6.59 billion € as per the data available in the year of 2012. The overall profit of the company can be counted as its marketing of 40 % in the highly growing regions while 90 % of the regions in which the firm has already been established among the top 3 producers of the products and services. Differently calculating all the stuff gives an overall idea of net selling of 2,986 billion €, 3,290 billion € and 6,155 billion € earning done by SOLVAY Chemicals, SOLVAY Plastics and SOLVAY Rhodia, respectively.
Three of the main divisions of the group: SOLVAY Chemicals, SOLVAY Plastics and SOLVAY Rhodia control the overall work of manufacturing and marketing of different products. SOLVAY Chemicals is the segment that is the largest manufacturer of sodium bi-carbonate, hydrogen peroxide and soda ash in the world and for the fluorinated chemicals; it is a leading firm on an international level. The second division, SOLVAY Plastics has the most diverse variety of plastics availability and is the leader manufacturer of the specialized vinyl’s and polymers worldwide. SOLVAY Rhodia is the third segment of the company which is a leading global unit and provider of specialized chemicals along with added value products serving a key for the services to the diverse fields of industry, consumer goods, home caring sector, health, fragrances, flavors, electronics and automobile.
The more specialized production of the company can be known by the example of the products including silica and other rare earth formations, designing of all being done to serve the marketing fields of surfactants, natural polymers and acetate tow. SolviCore is one of the undertakings made by collaboration of Umicore and Solvay to be used for as within fuel-cells, which is involved in the membrane electrode marketing assemblages for varied types of portable-batteries or for mobiles.
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 11,227 | 680,915 | 1.65 % |
2020 | 9,714 | 679,496 | 1.43 % |
2021 | 11,434 | 892,944 | 1.28 % |
2022 | 16,071 | 1,632,643 | 0.98 % |
2023 | 0 | 0 | 0.00 % |
Solvay now in top highest dividend yields in Belgium
Solvay among highest dividend stocks in Belgium
Stock Solvay goes ahead in Belgium in terms of dividend yields
Analysts expect over 2020 decreasing revenue Solvay, quite high dividend
Analysts recommend to buy Solvay
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the past year the company' stock gained around 17 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 77 percent. Solvay's revenues between 2011 and 2015 were relatively stable and moved between 12,83 billion euros and 11,05 billion euros. Solvay's net incomes between 2011 and 2015 were very volatile through the time and moved between 335 million euros and 509 million euros.
The company's head quarter is located in Brussels. Solvay is active in the diversified industrials sector. The global diversified companies gained around 53 percent over the period 2006-2016. Measured since 2011 the sector is 240 percent higher and over the past 12 months (December 2015-2016) there is a plus of 53 percent.
Solvay paid out dividends in the past 5 years. Over the past 5 years Solvay's dividend yield was at around 12,24 percent per year.
At the end of 2015 Solvay employed at around 29 thousand people.
At the end of 2015 the diversified company's balance sheet was worth 25,33 billion euros. Of the total balance sheet 15,91 billion euros (62,8 percent) was financed by debt. As per the end of 2015 Solvay's price/earnings-ratio equaled 15. So investors paid for 1 stock 15 times the earnings per share of 2015. Based on the classical stock valuation theories the Belgian stock can be seen as a value stock.
At the end of 2015 the diversified company's market capitalization (the number of shares times the market price) equaled around 8,04 billion euros. At the end of 2015 around 83,74 million stocks were listed.
All the annual reports of Solvay are available here. More information about Solvay can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
11,047
|
11,403
|
10,891
|
11,299
|
11,227
|
9,714
|
Costs |
10,641
|
10,782
|
9,830
|
10,533
|
11,224
|
10,795
|
Profit |
406
|
621
|
1,061
|
766
|
3
|
-1,081
|
Margin of profit |
3.68
|
5.45
|
9.74
|
6.78
|
0.03
|
-11.13
|
ROI |
4.31
|
6.40
|
11.01
|
7.29
|
0.03
|
-15.02
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
9,423
|
9,706
|
9,639
|
10,507
|
9,515
|
7,198
|
Debt |
15,906
|
14,439
|
11,812
|
11,493
|
11,792
|
9,594
|
Total assets |
25,329
|
24,145
|
21,451
|
22,000
|
21,307
|
16,792
|
Solvency |
37.20
|
40.20
|
44.93
|
47.76
|
44.66
|
42.87
|
Cash |
2,030
|
969
|
992
|
1,103
|
809
|
1,002
|
Cashflow |
1,289
|
1,788
|
1,590
|
1,720
|
1,815
|
1,242
|
Employees |
30,000
|
27,000
|
24,500
|
24,500
|
0
|
|
Revenue per employee |
0.37
|
0.42
|
0.44
|
0.46
|
0.0
|
|
Cashflow / Debt |
0.08
|
0.12
|
0.13
|
0.15
|
0.15
|
0.13
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
98.43
|
111.35
|
115.90
|
87.32
|
103.30
|
Eps |
5.99
|
10.19
|
7.38
|
0.03
|
-10.48
|
Price/earnings-ratio |
16.43
|
10.93
|
15.70
|
2910.67
|
-3.03
|
Dividend |
2.42
|
2.52
|
2.63
|
2.63
|
2.63
|
Dividend % |
2.46 %
|
2.26 %
|
2.27 %
|
3.01 %
|
8.29 %
|
Payout % |
0.40
|
0.25
|
0.36
|
87.67
|
-0.25
|
Book value |
94.03
|
93.29
|
101.86
|
92.01
|
69.78
|
Market to book |
0.96
|
0.84
|
0.88
|
1.05
|
2.20
|
Cashflow per stock |
17.32
|
15.39
|
16.67
|
17.55
|
12.04
|
Stocks |
103
|
103
|
103
|
103
|
103
|
Market Cap |
10.160.50
|
11.504.52
|
11.955.55
|
9.029.85
|
3.271.14
|
Date
|
Price
|
---|---|
13 Nov 2024
|
31.71
|
08 Nov 2024
|
33.73
|
05 Nov 2024
|
37.56
|
31 Oct 2024
|
37.03
|
29 Oct 2024
|
38.25
|
23 Oct 2024
|
38.90
|
19 Oct 2024
|
39.35
|
16 Oct 2024
|
39.32
|
14 Oct 2024
|
38.00
|
05 Oct 2024
|
37.51
|
02 Oct 2024
|
35.61
|
27 Sep 2024
|
34.12
|
20 Sep 2024
|
34.58
|
17 Sep 2024
|
31.45
|
13 Sep 2024
|
30.81
|
28 Aug 2024
|
31.14
|
26 Aug 2024
|
31.03
|
23 Aug 2024
|
31.23
|
11 Aug 2024
|
31.16
|
07 Aug 2024
|
30.89
|
05 Aug 2024
|
29.94
|
01 Aug 2024
|
32.52
|
30 Jul 2024
|
33.18
|
26 Jul 2024
|
33.42
|
23 Jul 2024
|
34.14
|
16 Jul 2024
|
32.28
|
10 Jul 2024
|
32.04
|
09 Jul 2024
|
33.95
|
04 Jul 2024
|
34.14
|
02 Jul 2024
|
31.91
|